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Background: The EU currently lacks reliable data on the prevalence and incidence of mental disorders in older
people. Despite the availability of several national and international epidemiological studies, the size and burden of
mental disorders in the elderly remain unclear due to various reasons. Therefore, the aims of the MentDis_ICF65+
study are (1) to adapt existing assessment instruments, and (2) to collect data on the prevalence, the incidence, and
the natural course and prognosis of mental disorders in the elderly.
Method/design: Using a cross-sectional and prospective longitudinal design, this multi-centre study from six
European countries and associated states (Germany, Great Britain, Israel, Italy, Spain, and Switzerland) is based on
age-stratified, random samples of elderly people living in the community. The study program consists of three
phases: (1) a methodological phase devoted primarily to the adaptation of age- and gender-specific assessment
tools for older people (e.g., the Composite International Diagnostic Interview, CIDI) as well as psychometric
evaluations including translation, back translation; (2) a baseline community study in all participating countries to
assess the lifetime, 12 month and 1 month prevalence and comorbidity of mental disorders, including prior course,
quality of life, health care utilization and helpseeking, impairments and participation and, (3) a 12 month follow-up
of all baseline participants to monitor course and outcome as well as examine predictors.
Discussion: The study is an essential step forward towards the further development and improvement of
harmonised instruments for the assessment of mental disorders as well as the evaluation of activity impairment and
participation in older adults. This study will also facilitate the comparison of cross-cultural results. These results will
have bearing on mental health care in the EU and will offer a starting point for necessary structural changes to be
initiated for mental health care policy at the level of mental health care politics.
Keywords: Mental health, Mental disorders, Elderly, Prevalence, Incidence, Health care use, ICF, Epidemiology* Correspondence: sandreas@uke.de
1Department of Medical Psychology, Centre for Psychosocial Medicine,
University Medical Centre Hamburg-Eppendorf, Martinistr. 52, Building W 26,
Hamburg D-20246, Germany
2Institute for Psychology, Alpen-Adria Universität Klagenfurt, Klagenfurt
A-9020, Austria
Full list of author information is available at the end of the article
© 2013 Andreas et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the orl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Andreas et al. BMC Psychiatry 2013, 13:62 Page 2 of 10
http://www.biomedcentral.com/1471-244X/13/62Background
Mental health in the elderly has become increasingly im-
portant in recent years. According to the Eurostat 2011-
based population projections, the number of people aged
65 and over is expected to rise by approximately 81% be-
tween 2010 and 2060 [1]. Older age is associated with an
increased frequency of disease, the need for additional
care and services, and leads to rising costs for health
care systems [2]. Furthermore, while society’s improved
ability to treat diseases and chronic conditions is a great
achievement, advances in health care have also led to
increased prevalence of many diseases in the elderly [3].
To keep pace with this continuing demographic shift,
more information on morbidity rates in the elderly and
particularly the size and burden of mental disorders is
needed to optimise mental health care and to provide
adequate services for elderly people.
There are two basic requirements towards this goal
that are currently not given. First, a reliable and
improved diagnostic instrument for the assessment and
evaluation of mental disorders in the elderly is urgently
needed. The standard instrument used for size and
burden assessment in the community has major
problems [4]. As evidenced by neuropsychological and
cognitive science research [4] the typically long interview
questions used in diagnostic interview lead to different
patterns of information processing, that in return
require older people to use heuristics that differ from
younger adults. As a result, elderly respondents deny
many symptom questions resulting in unreasonably low
estimates for any disorders.Figure 1 The Model of the International Classification of Functioning,
MentDis_ICF65+ project (ICF) [5].The second challenge is how to assess the functional
impairments and disabilities resulting from psychopath-
ology and mental disorders. In this respect the
International Classification of Functioning, Disability
and Health ICF [5], offers a good framework for
understanding the health status of people with mental
disorders.
The international classification of functioning, disability
and health (ICF)
The International Classification of Functioning, Disabil-
ity and Health (ICF) model [5] shows that while the
diagnosis is highly relevant, additional factors and
components can impact the quality of a person’s life [6]
(Figure 1). Thus, the ICF model is a useful framework
for describing the functioning of patients with mental
disorders [7,8]. The ICF is based on the bio-psycho-so-
cial model of health and disability and classifies func-
tionality at different levels [6]. The first component
refers to functioning and disability based on dimensions
of “body functions and structures” and “activities and
participation.” Two other components of the model are
the dimensions of “environmental factors” and “personal
factors” (Figure 1).
The level of “health condition” and “body functions and
structures” of the ICF
The level of health conditions for the ICF is dedicated to
various mental and physical diagnoses provided by the
International Classification of Diseases (ICD-10) [9].
Studies on the prevalence of mental disorders in theDisability and Health applied to the study aims of the
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atic literature review by Riedel-Heller et al. [10] shows
that a number of studies report the prevalence of
affective disorders and dementia in old age. For example,
estimated 1-year prevalence rates for depression – the
only disorder consistently examined – range from 3% to
10% [11]. For dementia, prevalence rates are estimated
between 0.6% and 3.7% for 65 to 69 year olds and 25.2%
to 75% for adults 90 years old or older. However, the
reported prevalence rates are extremely variable, and
significant reservations have been expressed regarding
the uncritical use of diagnostic interviews for adults in
elderly populations. To date, little empirical data are
available on the prevalence of other mental disorders
in the elderly. These few studies report prevalence
rates of substance-related (in particular alcohol-related)
disorders in elderly people (65 years or older) between
0.5 to 3.3%; for schizophrenia, schizotypal disorders and
many psychotic disorders, the rate is estimated at 10%;
rates of anxiety disorders are between 4 and 14%, while
somatoform disorders are estimated between 0.3 and
13% [10]. However, due to the heterogeneity of these
samples, it is difficult to generalise prevalence rates for
mental disorders across European countries. The few
European studies conducted to date focus either on the
prevalence of mental disorders in the general population
of 18 to 65 year olds [12] or on specific types of
disorders, e.g., affective disorders [13] or dementia [14].
Multiple studies have shown high comorbidity be-
tween mental disorders and physical illness in the elderly
[13,15-17]. Studies have also shown an interaction be-
tween different physical illnesses (e.g., diabetes mellitus,
cancer, cardiovascular disease) and the occurrence of de-
pression in the elderly [13]. Adamis and Ball [15]
reported a strong relationship between depression and
hypertension, diabetes and cardiovascular illnesses in the
elderly. In contrast, Newson [16] found no relationship
between atherosclerosis and depression in the elderly.
Braam et al. (2005) concluded that the link between
functional disability and depressive symptoms in later
life requires assessment and management of disabilities
when treating depression in older populations.
The level of “activities and participation” of the ICF
From the perspective of the ICF (see Figure 1),
additional factors associated with mental and physical
illness and functioning can be found to impair activities
and participation in older people. Currently, studies of
the degree to which older people are involved in
society are underway. For example, Agahi and Parker
[18] investigated the degree to which older adults
participated in leisure activities over a 10 year period in
Sweden. The results of that study showed that
individuals in their late 70s and early 80s were betterintegrated in society and more likely to be involved in
leisure activities if they had a higher education and
exercised more. Harvey et al. [19] also showed that
increased leisure-time activity was negatively associated
with symptoms of depression independent of activity
intensity.
The level of environmental factors of the ICF
Environmental factors based on the ICF include material
and social factors (e.g., health care services) as well as
attitudes regarding the environment in which a person is
living [5]. Most international studies agree that people
meeting the criteria for a mental disorder are typically
under recognised and untreated. Few patients receive
specialist care (e.g., psychotherapy, psychotropic medica-
tion or inpatient therapy) [17,20]. This lack of treatment
may cause higher health care costs (e.g., due to longer
hospital stays) [12,21,22]. For this reason, it is particu-
larly important to investigate the factors that hinder
people from utilising specialist treatment. To date, only
a few empirical studies have been conducted regarding
the predictors of service utilisation and the barriers to
utilisation faced by people who suffer from affective
disorders [20,23,24] and in European people between the
ages of 18 and 65 years [12]. Empirical studies have
identified a fairly consistent list of factors that influence
the utilisation of specialist treatment including the sever-
ity of the mental disorder [25], the perceived quality of
life, the existence of a mental disorder (especially
affective disorders) or multiple mental disorders, social
support (e.g., family status), age (the peak of utilisation
being between 35 to 49 years old) and gender [20,23,24].
Furthermore, it has been shown that as the incidence of
these characteristics increases, more specialist treatment
was used.
Objectives and research questions
To date, few studies have collected data on the preva-
lence of mental disorders in elderly populations [26], es-
pecially taking into account parts of the ICF
classification. There is also a strong need for greater
standardisation of methods to improve the quality and
comparability of epidemiological data in Europe.
Because the existing structured diagnostic interviews
are not appropriate for the elderly, the main aim of the
MentDis_ICF65+ (Mental Disorders in the elderly based
on the concept of the ICF) study is 1) to adapt a
structured diagnostic interview for the assessment of
mental disorders in older people according to ICD-10
and DSM-IV standards. Based on this adaptation 2)
prevalence rates of mental disorders in the elderly in dif-
ferent European and European associated countries will
be assessed along with incidence rates and their relation-
ship to symptom severity, levels of activity and
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ICF dimensions.
The following research questions (RQ) can be derived:
RQ 1: How feasible is an adapted version of a
standardised/structured diagnostic interview for the
needs of people age 65 and above in different European
and European associated countries?
RQ 2: How reliable and valid are the adapted and
translated standardised/structured diagnostic interview
and the newly translated instruments?
RQ 3: What are the point, year and lifetime prevalence
rates of mental and physical disorders among the elderly
population of different European and European-
associated countries and what is the relationship of this
prevalence to symptom severity, activities and participa-
tion and service utilisation?
RQ 4: What is the one-year incidence rate of mental
disorders among community respondents aged 65 and
above and what is the 12-month course and outcome
(prognosis) of mental disorders in older people in differ-
ent European and European associated countries?
Methods/design
Study design
The study design of the MentDis_ICF65+ study is
depicted in Figure 2. To answer RQ 1, a pre-test phase
was conducted. This phase was devoted to the adapta-
tion of age- and gender-specific assessment tools (e.g.,
Composite International Diagnostic Interview, CIDI)
and to the translation and back translation of these
instruments for older people. This step was completed
in the course of preparing this project. The preparations
included an in-depth review of the relevant literature
followed by an elaborate multi-level analysis of the
quality criteria for different assessment tools (e.g.,Multi-
centre 
study: 
Germany,
Italy, 
Spain,
Switzer-
land,
Israel and 
UK
RQ 1:
Pre-test 
N = 18
RQ 2:
Pilot-study 
N = 300
Figure 2 Design of the MentDis_ICF65+ study. Note: RQ = research quepracticability, reliability and validity), as well as language
availability and prior application in an elderly sample.
Following the selection of instruments, the process of
adaptation was conducted. Various methods were used
to test the feasibility, acceptability and usability of the
adapted instruments, including expert-panel review, re-
spondent debriefing, simple testing (interviewer feed-
back), and behaviour coding from a sample of 18
participants with and without mental disorders. This
study was conducted at two centres in Hamburg
(Germany) and London (UK) (see Figure 2).
For RQ 2, a pilot-phase will be undertaken. A sample
of 50 inpatients and outpatients in each of 6 countries
(for a total of 300 patients) will be chosen. These
patients presented with different mental and physical
disorders will be interviewed in Germany, Hamburg co-
ordinating centre of the study and Dresden as well as in
Italy Ferrara, Israel Jerusalem, Spain Madrid, Switzerland
Geneva and in UK London. To assess instrument reli-
ability, a subsample of 150 inpatients and outpatients
(25 from each country) with different mental and
physical disorders will be interviewed twice. The time
interval between the interviews shall be 3 to 7 days
(Figure 2).
To answer RQ 3 and 4, a stepwise cross-sectional and
prospective longitudinal design will be conducted. The
multi-centre study in six European countries and
associated states will be based on an age-stratified,
random sample of 3000 subjects living in selected catch-
ment community areas of each participating country
(500 subjects from each country). Additionally, all
participants in the cross-sectional study will be
contacted for follow-up participation one year later.
Based on prior experience from other studies, a response
rate of 85% can be expected within 1 year. Thus theage-stratified, random 
community sample
RQ 3:
Cross-sectional 
study
N = 3000
RQ 4:
Longitudinal 
study
N = 2550
Total duration: 4 Years
stion.
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countries for a total sample size of 2550 individuals.
Study participants
To answer RQ 1, 18 participants from two study centres
(London, UK and Hamburg, Germany) were interviewed
with the adapted instrument. Audio files from the
interviews were recorded. Each site interviewed a het-
erogeneous sample, equally distributed across two age
groups (65-74 and 75-85 years), both with and without
mental disorders.
Within the study pilot-phase (RQ 2), a sample of 50
inpatients and outpatients from each of the 6 participat-
ing countries (for a total of 300 patients) with different
mental or physical disorders will be interviewed. The
exclusion criteria will be severe cognitive impairments
(MMSE cut-off score > 27), insufficient level of cor-
responding language, and being younger than 65 or older
than 85 years of age.
Participant inclusion criteria RQ 3 and 4 are the abil-
ity to provide informed consent, living at home in the
predefined catchment area at the beginning of the cross-
sectional study, and ages between 65 and 85 years, re-
spectively. The exclusion criteria for the participants will
be severe cognitive impairment as assessed with the
MMSE (Mini-Mental State Examination, Mini cut-off
score > 27) [27] in the screening part of the diagnostic
instrument, making the administration of assessment
instruments impossible, and insufficient understanding
of the corresponding language. Qualified and trained
interviewers will screen patients for inclusion and exclu-
sion criteria. These interviewers will remain in close
contact with the study’s research staff.
Ethics and quality standards
The study was approved by research ethics committees
in all six centres (Germany: Hamburg Ethic committee
of the Medical Association No. 2895, Italy: Ferrara
No. 0096637 5/11/2009, Israel: Jerusalem No. 0376-09
-HMO, Spain: Madrid No. 22032010, Switzerland:
University Hospitals of Geneva ethics committee, Proto-
col No 09-121 and UK: National Research Ethics Service
No. 10/H0715/21).
The study centre in Hamburg, Germany, is responsible
for coordinating the study and for ensuring the accuracy,
quality, and input of the data collected. To complete the
cross-sectional and longitudinal components of the
study (RQ 3 and 4), interviewers must be trained to
administer the adapted version of the instruments.
Research staff from each study centre of the Ment-
Dis_ICF65+ project will be trained during a 1-2 day
workshop provided by the Dresden centre under the dir-
ection of Hans-Ulrich Wittchen. Afterwards, the re-
search staff of each centre will train up to 20interviewers per centre on procedures for conducting
the adapted interview. To ensure a high level of inter-
view standardisation between the different centres,
interviewers will be provided with protocols and
guidelines. The protocols will establish procedures for
opening the interview, evaluating difficult respondent
questions, and for stopping the interview. These rules
will be established by the study’s coordinating centre.
Interviewers will be monitored and supervised continu-
ously throughout the course of the study.
Study measures
Table 1 gives an overview of the core study measures for
the MentDis_ICF65+ project covering all domains of the
ICF (see also Figure 1). These instruments will be used
to answer RQ 3 and 4.
The Composite International Diagnostic Interview for the
elderly (CIDI65+)
The core instrument of the study is a standardised diag-
nostic interview used to collect data on the prevalence
and incidence of mental disorders in the elderly (RQ 3
and 4). The study group decided to adapt the widely
used “Composite International Diagnostic Interview”
[32] to the needs of the elderly. The study group
developed the CIDI65+ under the direction of the Dres-
den centre (H.-U. Wittchen). The CIDI65+ is adapted to
the particular social, cognitive and psychological abilities
and needs of the elderly. The interview evaluates somatic
morbidity, somatoform disorders, anxiety disorders
(panic, panic disorder, GAD, agoraphobia, social and
specific phobias), depressive disorders, bipolar disorders,
psychotic symptoms, obsessive-compulsive disorders,
substance abuse (screening sections for nicotine, alcohol,
drugs/medication), adjustment disorders, acute stress-
and post-traumatic stress disorders as well as cognitive
impairment. The adapted version of the CIDI will be
translated into all required languages.
The Health of the Nation Outcome Scales65+ (HoNOS65+)
Originally, the Health of the Nation Outcome Scales
(HoNOS) were developed for the routine assessment
of adults with mental disorders [33]. Additional
instruments, such as the HoNOS65+, have been
developed to augment the “HoNOS family”. The
HoNOS65+ is an instrument for assessing the sever-
ity level of 12 problem areas (e.g., item 7: depressive
mood; item 2: self-harm). These areas are assessed
on a scale from 0 (no problem) to 4 (severe to
very severe problem). A glossary containing anchor
examples for the allocation of individual ratings
(from 0 to 4) is available for the 12 problem areas.
Numerous studies have assessed the mostly satisfac-
tory psychometric properties of the HoNOS65+ [34].
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Britain and Australia where this instrument is being
used as part of the national health strategy as a
“Minimum Data Set.” Moreover, the HoNOS65+ is
one of the six most commonly used assessment
scales in elderly psychiatry services, providing key
material results for shaping the provision of psychi-
atric services for older individuals [35].
The short version of the Big Five Inventory (BFI-10)
To further assess personality traits as another important
component of the body function and structure domain
based on the ICF, we will use the short version of theTable 1 MentDis_ICF65+ assessment battery covering ICF
domains
ICF domain: personal factors
Instrument content
Adapted version of the Composite
International Diagnostic Interview for
the elderly (CIDI65+, Wittchen et al.,
in preparation)
sociodemography
ICF domain: health condition and body functions and structures
Instrument content
Adapted version of the Composite
International Diagnostic Interview for
the elderly (CIDI65+, Wittchen et al.,
in preparation)
screening for nicotine abuse
somatic, somatoform
disorders
anxiety disorders (including
HADS)
depressive disorders
bipolar disorders
psychotic symptoms
screening for alcohol abuse
(including AUDIT)
obsessive compulsive
disorders
screening for drugs and
medication abuse
posttraumatic stress disorder,
adjustment disorder
cognitive impairment (MMSE)
Health of the Nation Outcome
Scales65+ HoNOS-65+, [28]
symptom severity
10-item version of the Big Five
Inventory BFI-10, [29]
personality assessment
Shalev’s Coping Efficacy Scale (CES) assessment of coping efficacy
ICF domain: activities and participation
WHOQoL-BREF [30] quality of life
WHODAS II [31] Assessment of activities and
participation
ICF domain: environmental factors
service utilisation items on access to and
barriers of service utilisationBig Five Inventory (BFI-10). This instrument was
developed from the 44-item version of the BFI by
Rammstedt and John [29]. The BFI-10 covers five per-
sonality domains: extraversion, agreeableness, conscien-
tiousness, neuroticism, and openness on a five-point
Likert scale (1 = disagree strongly to 5 = agree strongly).
This shortened version of the BFI provides satisfactory
psychometric properties [29]. So far, the few existing
studies on the relationship between personality and
mental disorders in the elderly argue in favour of a di-
mensional approach of personality in late life [36].World Health Organization’s QOL measure (WHOQoL-BREF)
To measure the quality of life in mentally ill older
persons, the WHO Quality of Life short version
[WHOQoL-BREF, 30] will be used. The WHOQoL-
BREF was developed by the World Health Organization
[30] from the WHOQoL-100 item version as a 26-item
questionnaire and uses a five-point Likert scale to
assesses the individual’s perceptions in the context of
their culture and value systems, and their personal goals,
standards and concerns. The questionnaire measures
dimensions including physical and psychological well-
being, environmental factors and social support. The
psychometric properties were found to be satisfactory
[37]. Moreover, there is evidence, that the WHOQoL-
BREF can be successfully administered in older
people [38].World Health Organization disability assessment schedule II
(WHODAS II)
An assessment of activities and participation (based on
ICF categories) will be performed using the World
Health Organization Disability Assessment Schedule II
(WHODAS II) [31]. The WHODAS II is a generic in-
strument assessing the functional impairment of daily
activities in six different areas (including communication
and self-supply). An extended 36-item expert rating ver-
sion and a 12-item self-rating short version are available.
A study by Pösl [39] applied the extended version (36
items) of the WHODAS II as a self-rating instrument.
Satisfactory psychometric scores for patients with
affective disorders were reported regarding reliability
and validity. A study by Kim et al. [40] used the
WHODAS II in a sample of people aged 65 years and
older. In this study, the level of impairment measured by
the WHODAS II was more influenced by somatic
health, depression and cognitive functioning than by
sociodemographic factors. This study provided the
first evidence that the WHODAS II is an adequate
instrument for the assessment of these impairments
in old age.
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This short rating scale consists of four items addressing
domains of coping efficacy: ability to pursue task per-
formance, emotional control, ability to sustain rewarding
interpersonal contacts and ability to maintain positive
self-image.
The corresponding instruments (see above) will be
translated according to the criteria of the WHO [41], if
they are not yet available in each country. Following a
rating by independent experts and subsequent verifica-
tion, the instruments will be retranslated by a native
speaker blind to the translated version. Test authors will
then evaluate possible divergences in the retranslations
and work to resolve inconsistencies before incorporat-
ing these changes into the translated version. This
procedure will be repeated until a consensus be-
tween original and translated versions has been
reached. Semantic, content and technical corres-
pondence will be monitored consistently [42].Statistical methods
Power calculation
The project pre-test (RQ 1) was used to identify feasibil-
ity issues when using the adapted instruments. There-
fore, no power calculation is necessary.
The pilot-phase (RQ 2) of the study will be under-
taken to analyse the psychometric properties of the
adapted version of the CIDI65+ and the newly translated
instruments. A sample size of 300 participants would
provide 80% power to detect a medium effect size
(r = 0.30) according to Cohen [43], using a two-tailed
test at a significance level of <0.05.
The required sample size for answering RQ3 and RQ4
was calculated using an expected prevalence rate of 30%,
based on reported lifetime prevalence rates of mental
disorders from all age groups and countries. The
expected standard errors/widths of the 95% confidence
intervals for each prevalence estimate will be as follows
(see Table 2):
The minimum difference in prevalence rates between
two pre-specified countries that can be detected with a
power of 80% or 90% is 9.2% (from 34.6 to 25.4%, riskTable 2 Sample size calculation for the cross-sectional
and longitudinal study
Expected no.
of evaluable
patients
Expected
standard
error
Expected width of
95% confidence
interval
Overall 3,000 0.8% ± 1.7%
Country 500 2.0% ± 4.1%
5-years age group 1,000 1.4% ± 2.9%
5-years age group per
country
167 3.5% ± 7.1%reduction 32.0%) or 9.4% (from 34.7 to 25.3%, risk re-
duction 36.2%).Sampling and stratification (RQ 3 and 4)
Administrative differences in each country may require
the use of multiple sampling strategies. Samples will be
collected using either a register of residents or postal
residents (most centres), telephone numbers or a register
of primary care patients. Reasons for non-participation
and non-eligibility (e.g., cognitive impairment, problems
understanding the language) will be documented. In
addition, we will collect information about non-
responders (e.g., age and gender) to examine any select-
ive attrition effects.
Each study centre will define a catchment area prior to
recruitment. This catchment should be representative of
the region’s population with regard to social classes
(equal inclusion of areas with working, middle and
upper social class population), specific living conditions
of our age cohort (e.g., no exclusion of nursing homes)
and population structure (urban/rural). The main aim of
this approach is to estimate the centre-specific and the
overall prevalence of mental disorders in 65 to 85 year
olds as precisely as possible. To maximise estimator ac-
curacy, some strata may be oversampled. Therefore, all
the strata should be filled equally to reach equal
variances for equal proportions (see Table 3).
The resulting cohort will be drawn according to the
stratification criteria (Table 3). Each study centre will
draw a sample of at least 2000 persons based on an
expected response rate of 20 to 25%. All cross-sectional
study participants will be asked to participate again one
year later. Based on previous study experience, a 1-year
response rate of 85% can be expected. Thus, the study
aspires to collect a sample of 425 elderly individuals in
each country for a total sample size of 2550.Statistical analyses
To answer RQ 1, a feasibility analysis on the adapted in-
strument will be undertaken. This analysis will employ
methods including cognitive testing and behaviour
coding.
To test RQ 2, analyses of the psychometric properties
of the CIDI65+ and the newly translated instruments
(e.g., German version of the HoNOS65+) will beTable 3 Stratification sample of the MentDis_ICF65+
study
Age/gender 65 - < 75 75 - < 85 Total
Male 125 125 250
Female 125 125 250
Total 250 250 500
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test-retest reliability of the CIDI65+. Kappa values below
0.40 will be considered to have poor agreement, values
between 0.40 and 0.60 will have fair agreement, values
between 0.61 and 0.75 will be in good agreement and
values of 0.76 and above will have excellent agreement
[44]. Because sufficient sample sizes are required,
coefficients will only be calculated for those diagnoses
with a base rate of at least 10% (i.e., at least 15 cases
diagnosed in either the test or the retest interview).
Agreement within the continuous variables will be
measured using the Intraclass-Correlation-Coefficient
(ICC). The ICC will be calculated for variables of the
CIDI65+, including age of onset and duration of the dis-
order. Furthermore, the newly translated instruments in
each country will be analysed for reliability (e.g., internal
consistencies) and validity (e.g., criterion validity).
As the study aims to examine the prevalence and inci-
dence rates of mental disorders in the elderly of all six
countries and associated states (RQ 3 and 4), the data
from all the participating centres will be analysed in a
comprehensive statistical model. This model will provide
an estimate of 1) the global prevalence and 2) the 1-year
incidence of mental disorders. Mixed generalised linear
models, with country as a random effect and stratum
(age*sex) as a fixed effect, will be used to estimate preva-
lence and incidence. In addition, the BLUP estimators
returned by the model will be used to analyse differences
between the participating centres. For all estimators, the
corresponding confidence intervals will be denoted. The
estimated prevalence rates will be projected to the total
population of the participating countries based on the
publicly available population statistics to give an impres-
sion of the absolute number of elderly cases requiring
health care. These prevalence and incidence estimations
for mental disorders (point, 1-year and lifetime preva-
lence) in older people in absolute figures, and 95% confi-
dence interval and predictors of mental disorders on the
basis of binary logistic regression analyses (including
affective disorders as a variable criteria; and including age,
gender, education, living situation, and partner situation as
independent variables) should also be calculated. Further-
more calculation of odds ratios and confidence intervals,
comorbidity rates and correlations to physical disorders
should be performed. Regression analyses will be used to
predict levels of activities and participation (including
mental disorders, physical disorders or other independent
variable) and quality of life. Analyses using binary logistic
regression analyses (utilisation of professional services as a
dependent variable and the aforementioned independent
variables) and calculation of odds ratios and confidence
intervals will also be performed. In addition, data from
non-responders will be analysed to identify differences be-
tween responders and non-responders.Discussion
Due to the current state of the literature, thus far, no
empirical data exist that are based on a sufficiently
detailed and sound methodological assessment of mental
disorders in elderly people (65+) from different countries
in Europe and associated states. The aim of the
proposed study is to establish a common methodology.
Finally, the results of this population from this Europe-
wide project will, beyond the mentioned epidemiological
aims, provide vital information on professional service
provision as well as information on the utilisation of
relevant data for policy-making decisions.
The results of the study will contribute to the
following research areas:
– The adaptation and translation of instruments for the
assessment of mental and physical disorders in older
people (e.g., CIDI65+, WHODAS-II, HoNOS-65+)
– Establishing psychometric properties of and
harmonising instruments for application within
cross-sectional samples
– Establishing prevalence rates (point, year and
lifetime) of mental and physical disorders in the
elderly in different countries of the EU
– Identifying the level of mental disorder severity in
older people
– Identifying factors that promote and impair access
to health services
– Establishing levels of activity and impairment (based
on ICF concepts) in older people with mental and
physical disorders
– Rating the quality of life in older people with mental
and physical disorders
– Quantifying the one-year incidence rate of mental
disorders and the 12-month course and outcome of
mental disorders in older people in different
European countries
– Identifying predictors affecting the course of mental
and physical disorders of the elderly in the general
population of six different EU countries
For the first time, data on physical and mental illnesses,
their related problems and the need for support will be
collected. In addition, valuable instructions for daily health
care can be derived from the instruments developed for
the elderly population. This project considerably extends
the current level of knowledge. Furthermore, the longitu-
dinal design of the Ment-Dis_ICF65+ study allows for the
assessment of mental disorder incidence rates in the eld-
erly, providing new data that can be used for health policy
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